Literature DB >> 24912442

Distinct alterations in ATP-binding cassette transporter expression in liver, kidney, small intestine, and brain in adjuvant-induced arthritic rats.

Atsushi Kawase1, Sari Norikane, Ayaka Okada, Mamiko Adachi, Yukio Kato, Masahiro Iwaki.   

Abstract

Pathophysiological changes of infection or inflammation are associated with alterations in the production of numerous absorption, distribution, metabolism and excretion-related proteins. However, little information is available on the effects of inflammation on the expression levels and activities of ATP-binding cassette (ABC) transporters. We examined the effect of acute (on day 7) and chronic (on day 21) inflammation on the expression of ABC transporters in some major tissues in rat. Adjuvant-induced arthritis (AA) in rats was used as an animal model for inflammation. The mRNA levels of mdr1a and mdr1b encoding P-glycoprotein (P-gp) decreased significantly in livers of AA rats on day 21. Hepatic protein levels of P-gp, Mrp2, and Bcrp decreased significantly in membranes but not homogenates of AA rats after 7 days and after 21 days of treatment with adjuvant. Contrary to liver, protein levels of P-gp and Mrp2, but not Bcrp in kidney, increased significantly in membranes. The biliary excretion of rhodamine 123 was decreased in rats with chronic inflammation owing to decreases in efflux activities of P-gp. Our results showed that the expression of transporters in response to inflammation was organ dependent. In particular, hepatic and renal P-gp and Mrp2 exhibited opposite changes in membrane protein levels.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  ABC transporters; MRP; P-glycoprotein; active transport; disease state; disposition; efflux pumps; elimination; membrane transport/transporters; multidrug resistance transporters

Mesh:

Substances:

Year:  2014        PMID: 24912442     DOI: 10.1002/jps.24043

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.

Authors:  Yoshiaki Kimura; Mika Shibata; Mika Tamada; Noriyuki Ozaki; Kunizo Arai
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

2.  Changes in Radixin Expression and Interaction with Efflux Transporters in the Liver of Adjuvant-Induced Arthritic Rats.

Authors:  Atsushi Kawase; Misaki Nakasaka; Hatsune Bando; Saori Yasuda; Hiroaki Shimada; Masahiro Iwaki
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

3.  High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.

Authors:  Vibeke Andersen; Lotte K Vogel; Tine Iskov Kopp; Mona Sæbø; Annika W Nonboe; Julian Hamfjord; Elin H Kure; Ulla Vogel
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway.

Authors:  Yuan Xie; Nian Yu; Yan Chen; Kang Zhang; Hai-Yan Ma; Qing Di
Journal:  Mol Med Rep       Date:  2017-06-14       Impact factor: 2.952

5.  Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity.

Authors:  Zhaohui Guo; Miao Yan; Lei Chen; Pingfei Fang; Zhihua Li; Zimeng Wan; Sisi Cao; Zhenyan Hou; Shanshan Wei; Wenqun Li; Bikui Zhang
Journal:  Exp Ther Med       Date:  2018-08-17       Impact factor: 2.447

6.  Slc25a39 and Slc25a40 Expression in Mice with Bile Duct Ligation or Lipopolysaccharide Treatment.

Authors:  Atsushi Kawase; Momoko Hatanaka; Naoya Matsuda; Hiroaki Shimada; Masahiro Iwaki
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

7.  Systemic Mobilization of Breast Cancer Resistance Protein in Response to Oncogenic Stress.

Authors:  Małgorzata Szczygieł; Marcin Markiewicz; Milena Julia Szafraniec; Agnieszka Hojda; Leszek Fiedor; Krystyna Urbanska
Journal:  Cancers (Basel)       Date:  2022-01-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.